Phase 2 study of palmitoylethanolamide combined with luteoline in frontotemporal dementia patientsMartina Assogna, Giacomo Koch, Emanuele Cerulli Irelli et al.|Brain Communications|2025Cited by 5
Safety and efficacy of rotigotine in patients with frontotemporal dementia: a phase 2, double-blind, randomized, placebo-controlled, multicenter trialGiacomo Koch, Barbara Borroni, Martina Assogna et al.|The Lancet Regional Health - Europe|2025Cited by 3